| ID | Sequence | Length | GC content |
|---|---|---|---|
| GAACUAUAGUUGAAGGCUGCUGCCAAUACAACACCACUGUGAAACAGAA… | 2210 nt | 0.4276 | |
| AGAAACUUGCCCGUGCUCAAGAGAGGUGGGGAAAAAGAGUGAGAGGCGG… | 2533 nt | 0.4501 | |
| AGAAACUUGCCCGUGCUCAAGAGAGGUGGGGAAAAAGAGUGAGAGGCGG… | 2327 nt | 0.4379 | |
| AUUUUAGAGAGUUAAAAAGUAACAGACUGAGAUAAAAGCGAUCGUGGAA… | 2264 nt | 0.4192 | |
| AGCCUCUUGGAAAGGAAUCUCACUAGGGGCUUGACUGCGUGGGUCUGUA… | 922 nt | 0.5239 | |
| AACGGCGGAGCCGCCGGCCGGGCGCGGACCGGAGCGCGUGAGGCUCCGG… | 2503 nt | 0.4794 | |
| CCCCCUGCGCUCUCGCCAUCGCCCCGCAUUUACUCGCUGGAGGAGGGGG… | 2322 nt | 0.4367 | |
| AGCCUCUUGGAAAGGAAUCUCACUAGGGGCUUGACUGCGUGGGUCUGUA… | 2309 nt | 0.4301 |
The protein encoded by this gene interacts with calcineurin A and inhibits calcineurin-dependent signaling pathways, possibly affecting central nervous system development. This gene is located in the minimal candidate region for the Down syndrome phenotype, and is overexpressed in the brain of Down syndrome fetuses. Chronic overexpression of this gene may lead to neurofibrillary tangles such as those associated with Alzheimer disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]
A study in mice and humans identified several novel disease genes for sepsis-induced myocardial dysfunction, with the RCAN1 being previously confirmed to regulate this condition as mentioned in the introductory discussion [Yao et al. DOI:10.1016/j.ygeno.2024.110911]. A study in humans demonstrated that the RCAN1 was evaluated as a candidate mRNA marker for skin identification in forensic samples [Visser et al. DOI:10.1007/s00414-010-0545-2]. The investigation, which tested skin and various body fluids using quantitative real-time PCR, found that the RCAN1 showed non-specific amplification among the tested samples and was therefore not selected as a suitable marker for distinguishing skin from other forensically relevant tissues.